Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,719,624
  • Shares Outstanding, K 358,396
  • Annual Sales, $ 8,027 M
  • Annual Income, $ -560,000 K
  • 60-Month Beta 1.74
  • Price/Sales 1.38
  • Price/Cash Flow 3.31
  • Price/Book N/A
Trade BHC with:

Options Overview

Details
  • Implied Volatility 36.97%
  • Historical Volatility 24.12%
  • IV Percentile 5%
  • IV Rank 2.64%
  • IV High 129.71% on 09/04/20
  • IV Low 34.46% on 05/26/21
  • Put/Call Vol Ratio 0.79
  • Today's Volume 5,919
  • Volume Avg (30-Day) 8,906
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 401,513
  • Open Int (30-Day) 402,923

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.98
  • Number of Estimates 5
  • High Estimate 1.05
  • Low Estimate 0.94
  • Prior Year 0.47
  • Growth Rate Est. (year over year) +108.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.97 +2.83%
on 05/18/21
32.54 -8.45%
on 06/01/21
+0.54 (+1.85%)
since 05/17/21
3-Month
26.77 +11.28%
on 05/11/21
34.50 -13.65%
on 04/28/21
-3.52 (-10.57%)
since 03/17/21
52-Week
14.86 +100.47%
on 09/30/20
34.80 -14.40%
on 03/09/21
+9.99 (+50.45%)
since 06/17/20

Most Recent Stories

More News
Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software

QB and , /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that its affiliate has entered into an agreement...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today the results to date of its pending cash tender offer (the "Tender O�EUR...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)

and , /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, along with Clearside Biomedical, Inc. (Nasdaq: CLSD) ("Clearside"),...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
CLSD : 4.64 (+13.73%)
Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month

and , /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Prevent Blindness, the nation's oldest volunteer eye health...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by through the redemption of outstanding senior notes, using cash...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Bausch Health Announces Participation At The Jefferies Healthcare Conference

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that , chairman and chief executive officer; , senior vice president and corporate controller;...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of aggregate principal amount of...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Bausch Health Commences Cash Tender Offer For Any And All Of Its 7.00% Senior Secured Notes Due 2024

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today that it has commenced a cash tender o�EUR er (the "Tender Offer") to...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Conditional Redemption Of Existing Senior Secured Notes

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of aggregate principal amount of new senior secured...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)
Salix Will Feature New Data At Digestive Disease Week® 2021

, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies...

BHC : 29.79 (-0.40%)
BHC.TO : 36.79 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

3rd Resistance Point 31.18
2nd Resistance Point 30.70
1st Resistance Point 30.24
Last Price 29.79
1st Support Level 29.30
2nd Support Level 28.82
3rd Support Level 28.36

See More

52-Week High 34.80
Last Price 29.79
Fibonacci 61.8% 27.18
Fibonacci 50% 24.83
Fibonacci 38.2% 22.48
52-Week Low 14.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar